Search
Search
Close this search box.

Anti-Cannabis Group Calls on DOJ to Extend Rescheduling Comment Period to Collect More Data

A prohibitionist group, represented by Torridon Law PLLC, founded by former Attorney General William Barr, is urging the DEA to extend the public comment period for cannabis rescheduling.

Smart Approaches to Marijuana (SAM) submitted the request, arguing that the 60-day window is insufficient and should be extended by another 30 days to gather comprehensive feedback, Marijuana Moment reported.

SAM’s request emphasizes that rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act would be a significant policy shift, necessitating thorough stakeholder input. The group insists that more time is needed to collect data, particularly on the effects of marijuana on adolescent cognitive development, which they argue was overlooked by the Department of Health and Human Services (HHS).

SAM also raises concerns about the legal implications of the rescheduling proposal, including its alignment with international treaties. They cite a previous instance where the DEA allowed a 120-day comment period for a rulemaking process, arguing that the current proposal warrants similar consideration.

Amid these debates, SAM continues to oppose the rescheduling and is exploring legal options to challenge the proposed changes, urging supporters to voice their opposition. The organization also highlights that the DEA’s final decision remains uncertain, as indicated by recent comments from DEA Administrator Anne Milgram and HHS Secretary Xavier Becerra.

Some 20,000 comments are understood to have been submitted to the DOJ since the window opened last month.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?